Principal Financial Group Inc. decreased its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 6.7% in the fourth quarter, according to the company in its most recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback